Psychosomatic Medicine: Obesity

1. Psychosomatic Medicine: Obesity دکتر سید شهاب بنی هاشم متخصص روانپزشکی فلوشیپ سایکوسوماتیک استادیار دانشگاه علوم پزشکی شهید بهشتی بیمارستان طالقانی

4. Insight

6. PSYCHIATRIC COMORBIDITIES OF OBESITY

7. Depression

8. Depression • increased appetite and low energy(DSM-5)

9. Depression • increased appetite and low energy(DSM-5) • depression among obese patients19 to 66

10. Obesity may lead to depression

11. Obesity may lead to depression • affecting health andbody image

12. Obesity may lead to depression • affecting health andbody image • increasing functional impairment

13. Obesity may lead to depression • affecting health andbody image • increasing functional impairment • decreasing quality of lifeand physical activity

14. Obesity may lead to depression • affecting health andbody image • increasing functional impairment • decreasing quality of lifeand physical activity • adding to stigma

15. Depression may lead to obesity

16. Depression may lead to obesity • elevated stress reaction

17. Depression may lead to obesity • elevated stress reaction • impairing immunity

18. Depression may lead to obesity • elevated stress reaction • impairing immunity • negative cognitions

19. Depression may lead to obesity • elevated stress reaction • impairing immunity • negative cognitions • eating behaviors

20. Depression may lead to obesity • elevated stress reaction • impairing immunity • negative cognitions • eating behaviors • poor adherence to treatment

21. Anxiety

22. Anxiety • Affecting25 percent of the population

23. Anxiety • Affecting25 percent of the population • specific phobia, social phobiaand PTSD

24. Anxiety • Affecting25 percent of the population • specific phobia, social phobiaand PTSD • HPA axis dysfunction

25. Anxiety • Affecting25 percent of the population • specific phobia, social phobiaand PTSD • HPA axis dysfunction • cravings for high sugar and high fat

26. Anxiety • Affecting25 percent of the population • specific phobia, social phobiaand PTSD • HPA axis dysfunction • cravings for high sugar and high fat • Trauma

27. Anxiety • Affecting25 percent of the population • specific phobia, social phobiaand PTSD • HPA axis dysfunction • cravings for high sugar and high fat • Trauma

28. Anxiety • Affecting25 percent of the population • specific phobia, social phobiaand PTSD • HPA axis dysfunction • cravings for high sugar and high fat • Trauma Anxiety

29. Anxiety • Affecting25 percent of the population • specific phobia, social phobiaand PTSD • HPA axis dysfunction • cravings for high sugar and high fat • Trauma Anxiety

30. Anxiety • Affecting25 percent of the population • specific phobia, social phobiaand PTSD • HPA axis dysfunction • cravings for high sugar and high fat • Trauma Anxiety Eating disorder

31. Severe Mental Illness

32. Severe Mental Illness • schizophrenia • bipolar disorder

33. Severe Mental Illness • schizophrenia • bipolar disorder • 60 percent

34. Severe Mental Illness • schizophrenia • bipolar disorder • 60 percent • combination of atypicals and mood stabilizers

35. Psychiatric Medications and Weight Gain

36. Psychiatric Medications and Weight Gain • Olanzapine

37. Psychiatric Medications and Weight Gain • Olanzapine • Mirtazapine

38. Psychiatric Medications and Weight Gain • Olanzapine • Mirtazapine • divalporex

39. Substance Use Disorders

40. Substance Use Disorders • substance use remission often results in weight gain

42. Medications for weight loss

43. Indication

44. Indication • BMI>30 or

45. Indication • BMI>30 or • BMI >27 with serious comorbidities

46. Indication • BMI>30 or • BMI >27 with serious comorbidities • Diet

47. Indication • BMI>30 or • BMI >27 with serious comorbidities • Diet • exercise plan are essential

48. addiction and serious side effects

49. addiction and serious side effects • Amphetamines

50. addiction and serious side effects • Amphetamines • substance abuse